Ushani S Rajapaksa - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Frontiers in Oncology|December 28, 2020

Malignancy and IFITM3: Friend or Foe?Ushani S Rajapaksa, Chen Jin, Tao Dong

Proceedings of the National Academy of Sciences of the United States of America|July 25, 2012

HLA-B may be more protective against HIV-1 than HLA-A because it resists negative regulatory factor (Nef) mediated down-regulationUshani S Rajapaksa, Demin Li, Yan-Chun Peng, et al.

Plos One|July 26, 2016

A Comprehensive Analysis of the Impact of HIV on HCV Immune Responses and Its Association with Liver Disease Progression in a Unique Plasma Donor CohortYong-Hong Zhang, Yan Zhao, Ushani S Rajapaksa, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Frontiers in Oncology|December 28, 2020

Malignancy and IFITM3: Friend or Foe?Ushani S Rajapaksa, Chen Jin, Tao Dong

Proceedings of the National Academy of Sciences of the United States of America|July 25, 2012

HLA-B may be more protective against HIV-1 than HLA-A because it resists negative regulatory factor (Nef) mediated down-regulationUshani S Rajapaksa, Demin Li, Yan-Chun Peng, et al.

Plos One|July 26, 2016

A Comprehensive Analysis of the Impact of HIV on HCV Immune Responses and Its Association with Liver Disease Progression in a Unique Plasma Donor CohortYong-Hong Zhang, Yan Zhao, Ushani S Rajapaksa, et al.

Pageof 1